Therapeutic Area: Oncology Product Name: ALKS 4230
Highest Development Status: Preclinical Product Type: Large molecule
Partner/Sponsor/Collaborator: Colvis Oncology
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable June 22, 2020
The study evaluated the antitumor efficacy and mechanism of action of mALKS 4230, a mouse ortholog of ALKS 4230, and lucitanib as monotherapies and in combination in a preclinical syngeneic mouse model of colon cancer.
Lead Product(s): SH-105
Therapeutic Area: Oncology Product Name: Undisclosed
Highest Development Status: Preclinical Product Type: Undisclosed
Partner/Sponsor/Collaborator: Seroba Life Sciences
Deal Size: $8.3 million Upfront Cash: Undisclosed
Deal Type: Series A Financing June 06, 2020
The funding will support the advancement of the product pipeline, along with expansion of technical and commercial operations in both Ireland and the US.